Kalaya's Topical Carrier Base Gel provides customers with a unique delivery system for cannabis oil.
Kalaya Topical Base Gel
The Kalaya Topical Carrier Base Gel is an innovative new product that has been uniquely formulated to provide fast-acting relief from pain and inflammation, when combined with cannabis oil. This innovative product gives patients the option to apply their cannabis oil directly onto affected skin, joints and muscles, providing effective relief to a specific area.
This unique formulation enhances absorption and penetration of oil into the skin, versus applying the oil directly. It can be combined with any cannabis oil.
A hydroalcoholic gel, our formulation enhances the absorption of cannabis through the dermis layer of the skin.
Our Topical Carrier Base Gel can be combined with any cannabis oil, including CBD, THC, CBC, CBN, CBG, THCa, THCv and CBDa.
CBD (cannabidiol) is a phytocannabinoid that has come to prominence in medical applications due to its unique therapeutic profile and effects. CBD is non-intoxicating at therapeutically relevant doses and may reduce pain, anxiety and inflammation1. It has also been found to be a potent anti-epileptic1,2.
THC (delta 9 tetrahydrocannabinol) is the predominant intoxicating molecule in cannabis and gives rise to the euphoria associated with being “high". THC has therapeutic potential as an analgesic, anti-inflammatory and anti-emetic 1.
How to Mix the Topical Carrier Base Gel
Once mixed, the clear gel forms a luxurious topical cream of the same quality found at luxury cosmetics counters. This can then be applied to your skin in order to deliver cannabis directly to the affected area and enhance absorption.
To transform the Kalaya Topical Base Gel into a topical cream (using cannabis oil):
- First pour 60ml of oil directly into the gel jar and close the lid.
- Shake vigorously for approximately 10 seconds.
- Open and stir well with the spatula until the formulation transforms into a rich cream.
- During this mixing process, the gel will go through a phase change and transform from a gel into a cream.
- Shake before use and apply using the spatula.
Can I mix other oils with this gel?
We would not advise mixing the Kalaya Topical Carrier Base Gel with other oils. This product is designed to enhance absorption of cannabis oil onto the skin. If you would not ingest the essential oil that you're referencing, we would not recommend mixing it with this delivery system.
Why would I use this product?
If you are looking for the benefits of cannabis oil and are not interested in inhaling, ingesting or applying straight cannabis oil to the skin, the Kalaya Topical Carrier Base Gel provides you with an opportunity to (receive the benefits of cannabis oil) in the form of an absorption-enhancing cream.
What does it do when mixed with cannabis oil?
The Kalaya Topical Carrier Base Gel is designed to enhance the absorption of cannabis oil, when mixed together. For questions about the benefits of cannabis specifically, we'd recommend talking to your primary healthcare provider.
How is this different to your other pain relief products?
There is no CBD or THC in the Kalaya Pain Relief products. These formulations are designed with active ingredients, including Arnica, Menthol, Camphor, Eucalyptus, MSM and Methyl Salicylate to deliver fast-acting, long-lasting pain relief.
As a topical carrier base gel, this formulation is an absorption enhancer, not a pain reliever. On its own, the Kalaya Topical Carrier Base Gel does not have THC or CBD properties. However, when combined with cannabis oil, it transforms into a cream that when applied topically, enhances the absorption of cannabis oil to the skin.
1. Baron, E.P. (2018). Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis and Benefits in Migraine, Headache, and Pain : An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain, 58,1139-1186. Link to reference.
2. Szaflarski, J. P., Bebin, E. M., Comi, A. M., Patel, A. D., Joshi, C., Checketts, D., … Weschler, R. (2018). Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results. Epilepsia, 59, 1540-1548. https://doi.org/10.1111/epi.14477